FDA Inspection 1115622 — Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.
The FDA completed an inspection of Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. on Dec 13, 2019 in Jinhua. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 13, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinhua (China)